LIVE
Real-Time
NEWS MONITOR
--:--:--
⬤ LOW 18 Mar 2026, 17:12 UTC

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment - Slideshow

MARKETS
\
↗ Read Full Story ← Back to Monitors
Share: Twitter/X LinkedIn
Latest in Markets
⬤ LOW
Global AI trade could revive after recent pullback, J.P. Morgan says
CNBC TV18 - Business · 4 min ago
⬤ LOW
IPO express picks up steam: Anmol Industries, Koolking Industries, 5 other firms file draft papers with Sebi
Economic Times Markets · 5 min ago
⬤ LOW
XP Factory sells Boom Battle Bar for up to £11m
Investing.com · 5 min ago
⬤ LOW
SuperX launches AI token platform and apps in Singapore
Investing.com · 6 min ago
⬤ LOW
Perpetua Resources advances construction at Idaho gold project
Investing.com · 6 min ago
Terms of Service